Prostate specific antigen (PSA) testing for the diagnosis of prostate cancer (PCa) results in a high false-positive rate, mostly due to the detection of elevated PSA levels in the blood when there is a benign disease such as enlargement or inflammation of the prostate [1]. The gene discussed is KLK3; the disease is prostate carcinoma.